1 |
Jacobs F, Gaudio M, Benvenuti C, De Sanctis R, Santoro A, Zambelli A. Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+/HER2- Early Breast Cancer. Cancers (Basel) 2022;15. [PMID: 36612144 DOI: 10.3390/cancers15010148] [Reference Citation Analysis]
|
2 |
Miao J, Gao Y, Guan W, Yu X, Wang Y, Jiang P, Yang L, Xu L, You W. High level of LncRNA MAPKAPK5-AS1 predicts poor prognosis and contributes to the malignant proliferation and EMT of non-small cell lung cancer via sponging miR-490-3p from HMGB2. Genes Genom 2022. [DOI: 10.1007/s13258-022-01339-5] [Reference Citation Analysis]
|
3 |
Cirri D, Massai L, Giacomelli C, Trincavelli ML, Guerri A, Gabbiani C, Messori L, Pratesi A. Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent. Dalton Trans 2022. [PMID: 36000524 DOI: 10.1039/d2dt00836j] [Reference Citation Analysis]
|
4 |
Filatov VE, Iuzabchuk DA, Tafeenko VA, Grishin YK, Roznyatovsky VA, Lukianov DA, Fedotova YA, Sukonnikov MA, Skvortsov DA, Zyk NV, Beloglazkina EK. Dispirooxindole-β-Lactams: Synthesis via Staudinger Ketene-Imine Cycloaddition and Biological Evaluation. Int J Mol Sci 2022;23:6666. [PMID: 35743110 DOI: 10.3390/ijms23126666] [Reference Citation Analysis]
|
5 |
Gaál Z. Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation. Int J Mol Sci 2022;23:5838. [PMID: 35628648 DOI: 10.3390/ijms23105838] [Reference Citation Analysis]
|
6 |
Turk A, Calin GA, Kunej T. MicroRNAs in Leukemias: A Clinically Annotated Compendium. Int J Mol Sci 2022;23:3469. [PMID: 35408829 DOI: 10.3390/ijms23073469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|